Document is current
Any future updates will be listed below
-
Authors
Agostinelli, Veronica
Torresi, Giada
Tarantino, Valentina
Goteri, Gaia
Filosa, Alessandra
Barbisan, Francesca
Bartoli, Elisa
Bianchi, Francesca
Chiodi, Natalia
Ambrosini, Elisa
Ricci, Giulia
Lucarelli, Alessandra
Burattini, Michela
Biagioni, Alice
Chiariotti, Sara
Magi, Simona
Mentrasti, Giulia
Morgese, Francesca
Papa, Roberto
Petrelli, Riccardo
Berardi, Rossana
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 7 January 2025
First Online: 4 February 2025
Declarations
:
: Rossana Berardi has been involved as a consultant and expert witness for AstraZeneca, Bayer, Boehringher Ingelheim, EISAI, Gilead, Incyte, Lilly, Menarini, Merck, and MSD. Veronica Agostinelli has been involved as a consultant and expert witness for Amgen, Regeneron, and GSK. All other named authors confirm that they have nothing to disclose. Rossana Berardi is an Editorial Board member of Oncology and Therapy. Rossana Berardi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: The study was conducted in accordance with the precepts of Good Clinical Practice and the ethical principles of the Declaration of Helsinki. Results presented in this article contain no personally identifiable information from the study. Ethical review and approval were waived for this study as per current regulations. The approval by the Chief Medical Officer and by the Quality Manager was required and obtained (procedure reference: P001.DS). Informed consent was obtained from all subjects involved in the study through the CORM (Cancer Center) platform.
